Several clinically relevant antibiotics produce various interactions w
ith G-CSF. These interactions of cytokines and antibiotics explain fai
lures in clinical trials on sepsis. However they demand strongly trial
groups that analyse these interactions before using G-CSF and other c
ytokines in sepsis trials. In addition they emphasize again the import
ance of a clinically relevant animal model.